BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33590959)

  • 1. Predicting distant metastatic disease in differentiated thyroid cancer: a matched case-control study.
    Jaffar S; Jayasekara J; Aniss AM; Tsang VHM; Learoyd DL; Clifton-Bligh R; Gill AJ; Glover AR; Sidhu SB; Robinson B; Sywak M
    ANZ J Surg; 2021 Apr; 91(4):716-723. PubMed ID: 33590959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.
    Hirsch D; Levy S; Tsvetov G; Gorshtein A; Slutzky-Shraga I; Akirov A; Robenshtok E; Shimon I; Benbassat CA
    Endocr Pract; 2017 Oct; 23(10):1193-1200. PubMed ID: 28704099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors.
    Lee J; Soh EY
    Ann Surg; 2010 Jan; 251(1):114-9. PubMed ID: 19779325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
    Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
    Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer With Papillary Histology.
    Soe MH; Chiang JM; Flavell RR; Khanafshar E; Mendoza L; Kang H; Liu C
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3206-e3216. PubMed ID: 35556126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-Specific Survival Trends for Patients Presenting with Differentiated Thyroid Cancer and Distant Metastases in the United States, 1992-2018.
    Wilhelm A; Conroy PC; Calthorpe L; Shui AM; Kitahara CM; Roman SA; Sosa JA
    Thyroid; 2023 Jan; 33(1):63-73. PubMed ID: 36413032
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive risk factors for distant metastasis in pediatric differentiated thyroid cancer from Saudi Arabia.
    Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Rasheed M; Al-Haqawi W; Qadri Z; Siddiqui K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Front Endocrinol (Lausanne); 2023; 14():1228049. PubMed ID: 37867506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative analysis of distant metastasis in differentiated thyroid cancer.
    Chen D; Huang L; Chen S; Huang Y; Hu D; Zeng W; Wang M; Zhou W; Feng H; Wei W; Zhang C; Liu Z; Guo L
    Oncol Lett; 2020 Mar; 19(3):1985-1992. PubMed ID: 32194693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study.
    Yip L; Gooding WE; Nikitski A; Wald AI; Carty SE; Karslioglu-French E; Seethala RR; Zandberg DP; Ferris RL; Nikiforova MN; Nikiforov YE
    Cancer; 2021 Jun; 127(11):1779-1787. PubMed ID: 33539547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
    Sabet A; Binse I; Dogan S; Koch A; Rosenbaum-Krumme SJ; Biersack HJ; Biermann K; Ezziddin S
    Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
    Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
    Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distant Metastases From Childhood Differentiated Thyroid Carcinoma: Clinical Course and Mutational Landscape.
    Nies M; Vassilopoulou-Sellin R; Bassett RL; Yedururi S; Zafereo ME; Cabanillas ME; Sherman SI; Links TP; Waguespack SG
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1683-e1697. PubMed ID: 33382403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergic effects of histology subtype, tumor size, and lymph node metastasis on distant metastasis in differentiated thyroid cancer.
    Liu Z; Chen S; Huang Y; Hu D; Zeng W; Wang M; Zhou W; Chen D; Feng H; Wei W; Zhang C; Zhou L; Guo L
    Ann Transl Med; 2019 Oct; 7(20):533. PubMed ID: 31807515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases.
    Mihailovic J; Stefanovic L; Malesevic M; Markoski B
    Thyroid; 2009 Mar; 19(3):227-32. PubMed ID: 19265493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor Cells Correlate with Clinicopathological Features and Outcomes in Differentiated Thyroid Cancer.
    Qiu ZL; Wei WJ; Sun ZK; Shen CT; Song HJ; Zhang XY; Zhang GQ; Chen XY; Luo QY
    Cell Physiol Biochem; 2018; 48(2):718-730. PubMed ID: 30025398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poorly differentiated thyroid carcinoma and poorly differentiated area in differentiated thyroid carcinoma: is there any difference?
    Bichoo RA; Mishra A; Kumari N; Krishnani N; Chand G; Agarwal G; Agarwal A; Mishra SK
    Langenbecks Arch Surg; 2019 Feb; 404(1):45-53. PubMed ID: 30673845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.